Milestone achievement advances potential first FDA-approved disease-modifying therapy for pterygium, a condition affecting ...

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has kept Jefferies analysts bullish on the company following a fireside chat in New ...

At ASCO 2026, companies debuted data that could hold the potential to disrupt the frontline treatment paradigm for various subtypes of NSCLC.

Several abstracts and data presentations on emerging clinical research in metastatic colorectal cancer (mCRC) prompted expert ...

Currently, there are 10,000 human diseases without treatment. At the current rate of around 50 treatment approvals per year, ...

Jefferies Global Healthcare Conference 2026 June 4, 2026 9:55 AM EDTCompany ParticipantsPeter Griffith - Executive VP & ...

Pfizer INDovation programme supports 20 startups to propel India's next gen healthcare innovators: Our Bureau, Bengaluru Thursday, June 4, 2026, 12:20 Hrs [IST] FITT IIT Delhi, in ...

On Sunday, Dr. Brian Wolpin of the Dana-Farber Cancer Institute presented data on pancreatic cancer that is moving the field ...

It’s not often that you see a standing ovation at a medical conference. But over the weekend, a ballroom full of cancer specialists got to their feet to applaud a slide showing that Revolution ...

The AUA 2026 conference featured practice-changing abstracts in the field of urologic oncology. Urologists from Fox Chase ...

Detailed price information for Lixte Biotech Hlds (LIXT-Q) from The Globe and Mail including charting and trades.